Fig. 3From: A PK/PD model for the evaluation of clinical rifaximin dosage for the treatment of dairy cow mastitis induced by Escherichia coliThe effect of rifaximin on mastitis induced by E. coli in mouse after 12 dose regimens designed with 25, 50, 100, 200, 400, and 800 µg/gland and dosing intervals 12, and 24 h, which was expressed as ∆logl0CFU/glandBack to article page